Date posted: September 1, 2015, 6:00 am
In this episode, we discuss the therapeutic drug monitoring and dose adjustments for tacrolimus (Prograf) and lithium.
Date posted: August 11, 2015, 6:00 am
In this episode, we discuss the therapeutic drug monitoring and dose adjustments for valproic acid (Depakote/Depakene/Depakon) and digoxin (Lanoxin).
Date posted: July 21, 2015, 6:00 am
In this episode, we discuss the therapeutic drug monitoring and dose adjustments for warfarin (Coumadin) and phenytoin (Dilantin).
Date posted: June 30, 2015, 6:00 am
In this episode, we discuss malaria prophylaxis with atovaquone/proguanil, chloroquine, hydroxychloroquine, doxycycline, mefloquine, and primaquine.
Date posted: June 9, 2015, 6:00 am
In this episode, we discuss six pivotal drug classes that have been FDA approved within the past 20 years. This is part 2 of a 2 part episode.
Date posted: May 19, 2015, 6:00 am
In this episode, we discuss six pivotal drug classes that have been FDA approved within the past 20 years. This is part 1 of a 2 part episode.
Date posted: April 28, 2015, 6:00 am
In this episode, we interview Brad Cannon, PharmD regarding his career path in pharmacy and his viewpoints on the pharmacy profession.
Date posted: April 7, 2015, 6:00 am
In this episode, we discuss the optimal drug therapy for three different case vignettes -- depression, hypertension, and diabetes mellitus.
Date posted: March 16, 2015, 6:00 am
In this episode, we review historical and new treatment options for hepatitis C, including: peginterferon, rivabirin, boceprevir, telaprevir, sofosbuvir (Sovaldi), simeprevir (Olysio), ombitasvir/paritaprevir/ritonavir/dasabuvir (Viekira Pak), and ledipasvir/sofosbuvir (Harvoni).
May 18, 2015 - Correction added in the beginning of the episode regarding Viekira Pak dosing regimen.
Date posted: March 3, 2015, 6:00 am
In this episode, we discuss the pharmacology of oversedation, the importance of sedation minimization strategies in mechanically ventilated patients, and overview the sedatives and analgesics commonly used in this patient population.